| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976923 | Brachytherapy | 2012 | 5 Pages |
Abstract
Our approach of a single implantation procedure followed by five fractions of HDRBT was well tolerated with early results demonstrating a moderate response and local control rate with acceptable toxicities.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Neeta Kannan, Sushil Beriwal, Hayeon Kim, Christopher Houser, Robert Mogus, Paniti Sukumvanich, Alexander B. Olawaiye, Scott Richard, Joseph L. Kelley, Robert P. Edwards, Thomas C. Krivak,